Ageing is associated with diminished apoptotic cell clearance in vivo
暂无分享,去创建一个
D. Goukassian | K. Walsh | Y. Takemura | T. Aprahamian | Tamar Aprahamian | David A. Goukassian | Kenneth Walsh
[1] Terry M Therneau,et al. Prevalence of monoclonal gammopathy of undetermined significance. , 2006, The New England journal of medicine.
[2] John Savill,et al. A blast from the past: clearance of apoptotic cells regulates immune responses , 2002, Nature Reviews Immunology.
[3] Paul A. C. Cloos,et al. Post-Translational Modifications of Proteins: Implications for Aging, Antigen Recognition, and Autoimmunity , 2004, Biogerontology.
[4] J. Katz,et al. Innate immunity in aging: impact on macrophage function , 2004, Aging cell.
[5] J. Koziol,et al. Range of antinuclear antibodies in "healthy" individuals. , 1997, Arthritis and rheumatism.
[6] Pier Paolo Pandolfi,et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies , 1998, Nature Genetics.
[7] P. Butler,et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity , 1999, Nature Medicine.
[8] M. Rowley,et al. Reciprocal change with age in antibody to extrinsic and intrinsic antigens. , 1968, Lancet.
[9] V. Gilbertsen,et al. Lymphocyte phytohemagglutinin responsiveness, immunoglobulins and autoantibodies in aging humans. , 1973, Journal of immunology.
[10] M. Walport,et al. Hereditary deficiency of C3 in animals and humans. , 1993, International reviews of immunology.
[11] M. Ramos-Casals,et al. Systemic autoimmune diseases in elderly patients: atypical presentation and association with neoplasia. , 2004, Autoimmunity reviews.
[12] T. Fleisher,et al. A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome. , 2002, Clinical immunology.
[13] E. Kovacs,et al. The aging innate immune system. , 2005, Current opinion in immunology.
[14] D. Choubey,et al. Resistance to UV‐induced apoptosis in human keratinocytes during accelerated senescence is associated with functional inactivation of p53 , 2004, Journal of cellular physiology.
[15] T. Möröy,et al. Features of systemic lupus erythematosus in Dnase1-deficient mice , 2000, Nature Genetics.
[16] S. Kihara,et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. , 2007, The Journal of clinical investigation.
[17] D. Steinberg,et al. Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[18] M. Prelog. Aging of the immune system: a risk factor for autoimmunity? , 2006, Autoimmunity reviews.
[19] D. Finegood,et al. A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. , 2006, Journal of autoimmunity.
[20] J. Charles Jennette,et al. Delayed Apoptotic Cell Clearance and Lupus-like Autoimmunity in Mice Lacking the c-mer Membrane Tyrosine Kinase , 2002, The Journal of experimental medicine.
[21] D. Steinberg,et al. Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[22] R. Voll,et al. SLE--a disease of clearance deficiency? , 2005, Rheumatology.
[23] K. Tanaka,et al. Evaluation of apoptotic cells induced by ultraviolet light B radiation in epidermal sheets stained by the TUNEL technique. , 1999, The Journal of investigative dermatology.
[24] J. Piette,et al. Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. , 2004, Arthritis and rheumatism.
[25] Faten Gad,et al. Mechanisms and implications of the age‐associated decrease in DNA repair capacity , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] M. Marshall. ENZYMATIC OR PHARMACOLOGICAL FIBRINOLYSIS? , 1964, Lancet.
[27] P. Taylor,et al. A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo , 2000, The Journal of experimental medicine.
[28] D. Aw,et al. Immunosenescence: emerging challenges for an ageing population , 2007, Immunology.
[29] Takafumi Ogawa,et al. Age-related changes of human bone marrow: a histometric estimation of proliferative cells, apoptotic cells, T cells, B cells and macrophages , 2000, Mechanisms of Ageing and Development.
[30] C. Langford. Vasculitis in the geriatric population. , 2005, Clinics in geriatric medicine.
[31] W. Janssen,et al. Cell-Surface Calreticulin Initiates Clearance of Viable or Apoptotic Cells through trans-Activation of LRP on the Phagocyte , 2005, Cell.
[32] B. Gilchrest,et al. Topically applied diacylglycerols increase pigmentation in guinea pig skin. , 1995, The Journal of investigative dermatology.
[33] J. Lord,et al. Neutrophil ageing and immunesenescence , 2001, Mechanisms of Ageing and Development.
[34] A. Agar,et al. Effect of L‐Arginine on Age‐Related Changes in Macrophage Phagocytic Activity , 2004, Immunological investigations.
[35] Annalisa Capobianco,et al. Cutting Edge: Dissociation Between Autoimmune Response and Clinical Disease After Vaccination with Dendritic Cells , 2003, The Journal of Immunology.
[36] P. Linton,et al. Age-related changes in lymphocyte development and function , 2004, Nature Immunology.
[37] A. Kavanaugh,et al. Rheumatic disease in the elderly: rheumatoid arthritis. , 2005, Clinics in geriatric medicine.
[38] S. Akira,et al. Murine Dendritic Cell Type I IFN Production Induced by Human IgG-RNA Immune Complexes Is IFN Regulatory Factor (IRF)5 and IRF7 Dependent and Is Required for IL-6 Production1 , 2007, The Journal of Immunology.
[39] R. Coppo,et al. Circulating Fc-receptor blocking factors in IgA nephropathies. , 1985, Clinical nephrology.
[40] K. Takahashi,et al. Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype , 2005, The Journal of Immunology.
[41] T. Fleisher,et al. A composite picture of TcRα/β+ CD4-CD8- T cells (α/β-DNTCs) in humans with autoimmune lymphoproliferative syndrome , 2002 .
[42] E. Deconinck,et al. A single intravenous infusion of apoptotic cells, an alternative cell-based therapy approach facilitating hematopoietic cell engraftment, did not induce autoimmunity. , 2003, Journal of hematotherapy & stem cell research.
[43] P. Weiner,et al. Decline in mitogen induced proliferation of lymphocytes with increasing age. , 1987, Clinical and experimental immunology.
[44] M. Walport,et al. Lupus-Prone Mice Have an Abnormal Response to Thioglycolate and an Impaired Clearance of Apoptotic Cells 1 , 2003, The Journal of Immunology.
[45] T. Horiuchi,et al. Mutation of DNASE1 in people with systemic lupus erythematosus , 2001, Nature Genetics.
[46] R. Voll,et al. Impaired clearance of dying cells in systemic lupus erythematosus. , 2005, Autoimmunity reviews.